Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the sequenced treatment alternatives to relieve depression (STAR*D) study

Journal of Women's Health

Volumn 22, Issue 2, 2013, Pages 121-131

  Kornstein, Susan G ^a   Toups, Marisa ^b   Rush, A John ^c   Wisniewski, Stephen R ^d   Thase, Michael E ^e   Luther, James ^d   Warden, Diane ^b   Fava, Maurizio ^f   Trivedi, Madhukar H ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CONTRACEPTIVE AGENT;

ARTICLE; DEPRESSION; FAMILY HISTORY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REMISSION; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SOCIOECONOMIC FACTORS;

EID: 84873655689     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3479     Document Type: Article

References (39)

1. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003;74:5-13. (Pubitemid 36329172)
2. Michaud CM, Murray CJL, Bloom BR. Burden of disease- implications for future research. JAMA 2001;285:535-539. (Pubitemid 32656319)
3. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in chronic major and double depression. J Affect Disord 2000;60:1-11. (Pubitemid 30625239)
4. Marcus SM, Young EA, Kerber KB, et al. Gender differences in depression: Findings from the STAR&z.ast;D study. J Affect Disord 2005; 87:141-150. (Pubitemid 41039936)
5. Marcus SM, Kerber K, Rush AJ, et al. Gender differences in depression symptoms in treatment seeking adults: STAR&z.ast;D confirmatory analyses, Compr Psychiatry 2008;49:238-246.
6. Kornstein SG, Young EA, Harvey AT, et al. The influence of menopausal status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause 2010;17:828-839.
7. Young EA, Kornstein SG, Harvey A, et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psycho-neuroendocrinology 2007;32:843-853. (Pubitemid 47193171)
8. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imip-ramine in chronic depression. Am J Psychiatry 2000;157: 1445-1452.
9. Martényi F, Dossenbach M, Mraz K, Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: A double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 2001;11:227-232. (Pubitemid 32618645)
10. Thase ME, Entsuah R, Cantillon M, Kornstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: Sex-age interactions. J Womens Health 2005;14:609-616. (Pubitemid 41488679)
11. Pinto-Meza A, Usall J, Serrano-Blanco A, Suarez D, Haro JM. Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? J Affect Disord 2006;93:53-60. (Pubitemid 43833246)
12. Grigoriadis S, Kennedy SH, Bagby RM. A comparison of antidepressant response in younger and older women. J Clin Psychopharmacol 2003;23:405-407. (Pubitemid 36951184)
13. Raskin A. Age-sex differences in response to antidepressant drugs. J Nerv Ment Dis 1974;159:120-130.
14. Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 2001;9:393-399. (Pubitemid 33015126)
15. Zanardi R, Rossini D, Magri L, Malaguti A, Colombo C, Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur Neuropsycho-pharmacol 2007;17:400-405. (Pubitemid 46497659)
16. Freeman EW, Rickels, K, Sondheimer SJ, Polansky M. Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes. J Clin Psychopharmacol 2001; 21:450-542.
17. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR&z.ast;D) study. Psychiatr Clin North Am 2003; 26:457-494. (Pubitemid 36583573)
18. Rush AJ, Fava M, Wisniewski SR, et al. STAR&z.ast;D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR&z.ast;D): Rationale and design. Control Clin Trials 2004;25:119-142. (Pubitemid 38230109)
19. Hamilton M. A rating scale for depression. J Neurol Neu-rosurg Psychiatry 1960;23:56-62.
20. Trivedi MH, Rush AJ, Wisniewski SR, et al. STAR&z.ast;D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR&z.ast;D: Implications for clinical practice. Am J Psychiatry 2006;163:28-40. (Pubitemid 43050100)
21. Linn BS, Linn MW, Gurrel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-626.
22. Miller MD, Towers A. A manual of guidelines for scoring the Cumulative Rating Scale for Geriatrics (CIRS-G). Pittsburgh, PA: University of Pittsburgh, 1991.
23. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583. (Pubitemid 37289444)
24. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 2004;34:73-82. (Pubitemid 38139442)
25. Zimmerman M, Mattia J. A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001;58:787-794. (Pubitemid 32717805)
26. Rush AJ, Zimmerman M, Wisniewski SR, et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005;87:43-55. (Pubitemid 40828202)
27. Rush AJ, Giles DE, Schlesser MA, Fulton C, Weissenburger JE, Burns C. The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Res 1986;18:65-87. (Pubitemid 16085767)
28. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 1996;26:477-486. (Pubitemid 26142491)
29. Novick JS, Stewart JW, Wisniewski SR, et al. Clinical and demographic features of atypical depression in outpatients with major depression: Preliminary findings from STAR&z.ast;D. J Clin Psychiatry 2004;66:1002-1011. (Pubitemid 41191792)
30. Khan AY, Carrithers J, Preskorn SH, et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 2006;18:91-98. (Pubitemid 43879896)
31. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR&z.ast;D. Psychol Med 2004;34:1299-1308. (Pubitemid 39517160)
32. Mundt JC. Interactive voice response systems in clinical research and treatment. Psychiatr Serv 1997;48:611-612.
33. Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ. Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput 1999;16:64-68.
34. Ware JE Jr, Sherbourne DC. The MOS 36-item Short Form health survey (SF-36). I. conceptual framework and item selection, Med Care 1992;30:473-483.
35. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q): A new measure. Psychopharmacol Bull 1993;29:321-326. (Pubitemid 23311543)
36. Mundt JC, Marks IM, Shear MK, Greist JH. The Work and Social Adjustment Scale: A simple measure of impairment in functioning. Br J Psychiatry 2002;180:461-464. (Pubitemid 34499343)
37. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR&z.ast;D measurement-based care. Neu-ropsychopharmacology 2007;32:2479-2489. (Pubitemid 350126843)
38. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA, for the STAR&z.ast;D Investigators. Self-rated global measure of the Frequency, Intensity, and Burden of Side Effects. J Psychiatr Pract 2006;12:71-79. (Pubitemid 44284089)
39. Wisniewski SR, Eng H, Meloro L, et al. Web-based communications and management of a multi-center clinical trial: The Sequenced Treatment Alternatives to Relieve Depression (STAR&z.ast;D) project. Clin Trials 2004;1:387-398.